Ascendis Pharma AS Strategic Asset Allocation Index
Ascendis Pharma AS strategic asset allocation index. Ascendis Pharma AS (A71) has a Strategic Asset Allocation Index of 4.8% as of March 2026. Strategic assets (PP&E of €- plus long-term investments of €23.56 Million) total €23.56 Million, measured against net assets of €487.97 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Ascendis Pharma AS to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Ascendis Pharma AS (2016–2022)
Strategic asset allocation index of Ascendis Pharma AS from 2016 to 2022. This chart shows how Ascendis Pharma AS's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of March 2026, the index stands at 4.8%, representing strategic assets of €23.56 Million against net assets of €487.97 Million EUR. Check A71 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Ascendis Pharma AS Strategic Asset Allocation Index by Year (2016–2022)
Ascendis Pharma AS strategic asset allocation index by year from 2016 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Ascendis Pharma AS from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Ascendis Pharma AS (A71) total market value.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 11.6% | €30.42 Million | €- | €30.42 Million | €263.35 Million | ▼ -19.2 pp |
| 2021 | 30.8% | €271.95 Million | €126.05 Million | €145.91 Million | €883.63 Million | ▲ +3.0 pp |
| 2020 | 27.7% | €232.57 Million | €108.11 Million | €124.46 Million | €838.71 Million | ▲ +17.6 pp |
| 2019 | 10.1% | €60.61 Million | €45.07 Million | €15.54 Million | €597.11 Million | ▲ +2.5 pp |
| 2018 | 7.6% | €21.41 Million | €4.33 Million | €17.08 Million | €280.05 Million | ▲ +6.3 pp |
| 2017 | 1.4% | €2.56 Million | €2.56 Million | €0.00 | €187.21 Million | ▲ +0.0 pp |
| 2016 | 1.3% | €2.35 Million | €2.35 Million | €- | €176.61 Million | — |